Conference Abstract
 
Navigation
Conference Abstracts Index

Abstracts - 2006 London

Abstracts - 2005 Zurich

Abstracts - 2004 Berlin

Abstracts - 2003 Barcelona

Abstracts - 2002 Brussels

Abstracts - 2001 Tokyo

Abstracts - 2000 Marburg

       

S7 ANDROGENETIC ALOPECIA: IN VIVO MODELS

1Sundberg J.P., 1Beamer W.G., 2Uno H, 3Van Neste D., 4King L.E, and 5Bascom C..  1The Jackson Laboratory, Bar Harbor, ME, U.S.A; 2University of Wisconsin Regional Primate Center, Madison, WI, U.S.A.; 3Skin Study Centre, Tournai, Belgium; 4Dept. of Dermatology, Skin Disease Research Center, Vanderbilt University and Bureau of Veterans Affairs, Nashville, TN, U.S.A.; and 5The Procter & Gamble Company, Cincinnati, OH, U.S.A.

Androgenetic alopecia is the most common form of balding in humans.  There is great interest in finding a reliable animal model to study the pathogenesis and treatment of this abnormality.  The stump-tailed macaque (Macaca artoides) has been the standard model and appears to be a useful homologue.  These primates are reasonably good predictors of compound efficacy.  Due to reduced size and expense, rodent models have been sought.  Testosterone inducible models require more development but offer potential.  Xenografts of human skin to immunodeficient mice, notably nude or severe combined immunodeficiency mutants, are small, relatively inexpensive, and easy to work with if a source of human tissue is available.  Xenografts to double mutant mice for severe combined immunodeficiency and a number of hormone receptor null mutations offer new refinements to these xenograft models.